AMP-activated protein kinase alpha-2 beta-2 gamma-3 heterotrimer (AMPK alpha-2 beta-2 gamma-3)

AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that serves as a master regulator of cellular energy homeostasis. The alpha-2 beta-2 gamma-3 (alpha2beta2gamma3) heterotrimer is a tissue-specific isoform predominantly localized in skeletal muscle, where it plays a pivotal role in responding to metabolic demands during physical exertion (Wojtaszewski et al., 2005, J Biol Chem). It is activated by a rise in the AMP/ATP ratio, leading to the phosphorylation of downstream targets that enhance glucose uptake and lipid oxidation while suppressing biosynthetic pathways (Hardie, 2014, J Intern Med). This specific heterotrimer is of significant therapeutic interest because its activation mimics the metabolic benefits of exercise, making it a target for treating type 2 diabetes and metabolic syndrome (Birk & Wojtaszewski, 2006, Diabetes). Drugs like MK-8722 and other small-molecule activators target the allosteric drug and metabolite (ADaM) site to increase the enzyme's activity independently of energy status (Myers et al., 2017, Sci Transl Med). However, therapeutic development must balance metabolic benefits against potential risks such as cardiac hypertrophy, which has been linked to chronic AMPK overactivation in certain contexts (Steinberg & Carling, 2019, Nat Rev Drug Discov).

Other names

PRKAA2/PRKAB2/PRKAG3 complex5'-AMP-activated protein kinase subunit alpha-2/beta-2/gamma-3AMPK alpha2beta2gamma3AMPK alpha-2 beta-2 gamma-3

Direct allosteric activation via the Allosteric Drug and Metabolite (ADaM) site and indirect activation via sensing of increased AMP:ATP ratios, which promotes phosphorylation of the alpha-subunit at Thr172 by upstream kinases such as LKB1 (Hardie, 2014, J Intern Med; Steinberg & Carling, 2019, Nat Rev Drug Discov).